4-tert-Butylphenylboronic acid

We are 4-tert-Butylphenylboronic acid CAS:123324-71-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 4-tert-Butylphenylboronic acid
Other Name:
4-tert-Butylphenylboronic acid
4-(Tert-Butyl)Phenylboronic Acid
4-tert-Butylbenzeneboronic Acid
CAS No: 123324-71-0
MF: C10H15BO2
MW: 178.03600
Density: 1.02 g/cm3
Boiling point: 296.7ºC at 760 mmHg
Melting point: 191-196 °C(lit.)
Flash point: 133.2ºC
Refractive index: 1.59
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White to off-white crystalline powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Pharmaceutical intermediate, pesticide intermediate, OLED intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-tert-Butylphenylboronic acid


Related News: The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.4,6-dibromothieno[3,4-c]furan-1,3-dione As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.4- (2-metilpropil) oxano-2,6-diona CAS:185815-59-2 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.4-nitroisoindolin-1-ona CAS:366452-97-3 Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.

Related Products
Product Name
1-(2,5-Dichloro-4-sulfophenyl)-3-methyl-5-pyrazolone Monohydrate View Details
6-Fluoro-2-methyl-1H-indole View Details
2-Aminoethyldiisopropylamine View Details
5-piperazin-1-yl-1-benzofuran-2-carboxamide manufacturer ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATE manufacturer 3-bromo-1-phenyl-5-pyridin-2-ylpyridin-2-one manufacturer Dynorphin A (1-13) manufacturer 2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate manufacturer